Article info
Clinical science
Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone
- Correspondence to Dr Bert Mueller, Department of Ophthalmology, Charité Campus Virchow Klinikum, Augustenburger Platz 1, Berlin 13353, Germany; Bert.mueller{at}charite.de
Citation
Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone
Publication history
- Received January 7, 2016
- Revised April 22, 2016
- Accepted May 18, 2016
- First published June 14, 2016.
Online issue publication
February 22, 2017
Article Versions
- Previous version (14 June 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/